Us Latin America Chronic Wound Care Market Report: Market Size & Forecast 2026

The Latin America chronic wound care market represents a significant and growing segment of the region's broader healthcare industry, focused on the treatment of wounds that fail to progress through normal stages of healing. Valued at approximately $23.3 billion in 2025, this market encompasses advanced dressings, biologics, negative pressure wound therapy devices, and emerging technologies such as extracellular vesicle-based treatments. Chronic wounds impose a substantial economic burden on regional health systems, with costs driven by prolonged treatment timelines, hospitalization, and the need for specialized care.

• •Market valued at approximately $23.3 billion in 2025 with a CAGR of 6.3%
• •Chronic wounds include diabetic foot ulcers, venous leg ulcers, pressure injuries, and burn wounds
• •Wound care product markets globally are projected to reach between $19.52 billion and $30.52 billion by 2029-2030

The market's expansion is primarily fueled by the rising prevalence of diabetes and associated complications across Latin America, which significantly increases the incidence of chronic wounds. Aging demographics throughout the region further contribute to higher wound care demand, as elderly populations are more susceptible to pressure injuries and slower-healing wounds. Rising individual and government healthcare expenditures are enabling greater investment in advanced wound management products and technologies.

• •Rising diabetes prevalence increases chronic wound incidence across Latin American populations
• •Growing aging demographics drive demand for wound care products in the region
• •Increasing healthcare expenditures support adoption of advanced wound management technologies

Latin America is consistently identified as a key regional growth segment within the global wound care market, with its medical technology sector expected to expand at an 8.6% CAGR. The market encompasses both conventional wound care products and emerging advanced therapies, including nanobased formulations and bioactive treatments derived from natural compounds. The region's shift toward over-the-counter consumer health products for wound management complements the institutional healthcare segment between 2022 and 2030.

• •Latin America MedTech sector expected to grow at 8.6% CAGR
• •Market includes conventional dressings, advanced biologics, and emerging nanobased formulations
• •Growing consumer health and OTC wound care product segment across the region

What are the recent trends and outlook?

The market is moving toward more sophisticated treatment modalities, including extracellular vesicle-based therapies, anti-inflammatory and antioxidant botanical extracts, and nanobased delivery systems for enhanced wound healing. Research into molecular pathways and bioactive compounds, such as flavonoids, is expanding the pipeline of potential therapeutic options. From 2025 through the early 2030s, continued growth is expected as healthcare systems in the region modernize, diabetes management improves, and new product innovations become clinically validated and commercially available.

• •Emerging research on extracellular vesicles and nanobased emulsions for refractory wound healing
• •Growing interest in natural bioactive compounds such as botanical extracts and flavonoids
• •Continued expansion expected through 2030 as regional healthcare infrastructure modernizes